Author

G. Perea

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:imaging· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. Araque· 1 shared A. Llado· 1 shared A. Llebaria· 1 shared A. Miranda-Vizuete· 1 shared A. Perez-Alvarez· 1 shared A. Santi· 1 shared A. Trueba· 1 shared A.M. Fernandez· 1 shared

Activity by Year

2015-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

A. Araque

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reversible silencing of endogenous receptors in intact brain tissue using two-photon pharmacology

S. Pittolo, H. Lee, A. Llado, S. Tosi, M. Bosch, L. Bardia, X. Gomez-Santacana, A. Llebaria, E. Soriano, J. Colombelli, K. E. Poskanzer, G. Perea, P. Gorostiza

This paper introduces two-photon pharmacology to reversibly silence mGlu5 receptors in intact brain tissue, enabling study of synaptic and signaling processes.

bioRxiv · Jan 10, 2019Pharmacology & Toxicology

INSULIN GROWTH FACTOR I AND ITS RECEPTOR ARE ANTAGONISTIC MODULATORS OF GLUCOSE HANDLING BY ASTROCYTES

E. Hernandez-Garzón, A.M. Fernandez, A. Perez-Alvarez, S. Mederos, P. Perez-Domper, P. Bascuñana, R.F. de la Rosa, M. Delgado, M.A. Pozo, A. Miranda-Vizuete, D. Guerrero-Gomez, E. Moreno, P.J. McCormick, A. Santi, L. Genis, , I. Torres Aleman

The paper shows that unliganded IGF-IR inhibits astrocyte glucose uptake while IGF-I and insulin synergistically enhance it through MAPK/PKD and Rac1/GIPC1 pathways.

bioRxiv · Jul 31, 2015 · PreprintNeuroscience